BioXcel Therapeutics has announced a clinical reprioritization, focusing on late-stage development of its agitation treatment ...

BioXcel Therapeutics (BTAI) stock gains as company shifts focus from commercial support for FDA-approved drug, Igalmi to lead ...

Patients undergoing complex gastrointestinal malignancy surgeries experience various challenges such as immune system ...

Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia ...

Research on using sedation to improve patient tolerance to noninvasive ventilation (NIV) after traumatic chest injuries is ...

Mr Kim called for the site to increase its production of nuclear warheads, state media said. Brazil and Argentina are both defeated in their latest qualifying matches for the 2026 Fifa World Cup ...

A study on the effects of commonly used anaesthetic and sedative drugs on cerebrospinal fluid flow and volume has uncovered findings regarding their impact on the brain's vital glymphatic system.

Notwithstanding a recent easing of supply constraints for some weight-loss medicines, the country is still mired in a record prescription drug shortage. Novo Nordisk’s popular GLP-1 drug Ozempic will ...

September 3, 2024 • A beloved beluga whale with a mysterious past was found dead in the waters of Norway over the weekend. Admirers are paying tribute as authorities investigate.

Dexmedetomidine hydrochloride 1 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase III for Pain. According to GlobalData, Phase III drugs for Pain have a 54% phase ...

The granted patent US11998529B2 outlines a method for treating agitation in human subjects using an oromucosal formulation of dexmedetomidine. The treatment protocol involves administering an initial ...